Sc. Lu et al., PROGRESSIVE DEFECT IN BILIARY GSH SECRETION IN STREPTOZOTOCIN-INDUCEDDIABETIC RATS, American journal of physiology: Gastrointestinal and liver physiology, 35(2), 1997, pp. 374-382
This study examined the effect of streptozotocin-induced diabetes on b
iliary reduced glutathione (GSH) efflux. Biliary GSH efflux was measur
ed before and after acivicin, an irreversible inhibitor of gamma-gluta
myl transpeptidase (GGT). One week after streptozotocin treatment, liv
er GGT activity doubled in diabetic rats but was inhibited by similar
to 90% after acivicin to levels comparable to controls. Despite maxima
l GGT inhibition, biliary GSH efflux in untreated diabetic rats decrea
sed progressively to similar to 10% of control levels by week 4 and wa
s partially restored by insulin. The mechanism for the decrease in bil
iary GSH efflux was not increased paracellular permeability. GSH trans
port kinetics, ATP-stimulated taurocholate, and oxidized glutathione (
GSSG) transport in canalicular liver plasma membrane prepared from dia
betic and control rats were similar. Inhibition of protein kinase C (P
KC) with high-dose H-7 increased biliary GSH efflux in diabetic animal
s to near control basal levels. In conclusion, streptozotocin-induced
diabetic rats exhibit a progressive impairment in biliary GSH transpor
t. One of the responsible mechanisms is heightened PKC tone in diabeti
c animals.